Product NewsLife Sciences

Webinar: Biomek FXP as a Tool for Discovery of Targets and Compounds for a Host-Directed Therapy of Influenza

5 Mar 2015
Webinar: Biomek FXP as a Tool for Discovery of Targets and Compounds for a Host-Directed Therapy of Influenza

Markus Lesch, Steinbeis gGmbH/ Max Planck Institute for Infection Biology delivers a webinar demonstrating the use of the Beckman Coulter Biomek FXP in target discovery for host-directed therapy of influenza.

About the company

Beckman Coulter Diagnostics logo

Beckman Coulter Diagnostics

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company s 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.

4.5/5.0
|152 Reviews

Other videos from Beckman Coulter Diagnostics

Links